[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349881-105":59,"doc-detail-349881-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","research-progress-on-early-diagnostic-markers-for-pancreatic-cancer","Research progress on early diagnostic markers for pancreatic cancer","","Pancreatic cancer (PC) is an aggressive malignancy with insidious onset, rapid progression, and poor prognosis, affecting mainly middle-aged and elderly men. Early diagnosis relies on biomarker detection using both traditional and emerging targets. Traditional markers such as CA 19−9 can produce false negatives in Lewis antigen-negative individuals, motivating multi-parameter strategies combining indicators like CEA and CA 242. Recent advances include liquid biopsy and exosome-based biomarkers, which are non-invasive and show improved sensitivity and specificity. However, gaps remain: single traditional biomarkers have limited performance and novel markers often lack extensive clinical validation. This narrative review summarizes recent research progress and evaluates biomarkers for early PC diagnosis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/research-progress-on-early-diagnostic-markers-for-pancreatic-cancer/349881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/research-progress-on-early-diagnostic-markers-for-pancreatic-cancer/349881.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why are early diagnostic biomarkers important for pancreatic cancer?","Question",{"text":112,"@type":113},"Pancreatic cancer has an aggressive course and poor prognosis, so identifying it early is critical. Biomarker detection is the most widely used approach for early diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What limitations exist for traditional biomarkers like CA 19−9?",{"text":117,"@type":113},"Traditional biomarkers can have false negatives in Lewis antigen-negative individuals and may show insufficient sensitivity and specificity.",{"name":119,"@type":110,"acceptedAnswer":120},"How do multi-parameter detection strategies improve early diagnosis?",{"text":121,"@type":113},"Combining core indicators such as CEA and CA 242 can strengthen diagnostic performance and support better decisions regarding diagnosis and treatment.",{"name":123,"@type":110,"acceptedAnswer":124},"What novel biomarker approaches are highlighted in recent research?",{"text":125,"@type":113},"Liquid biopsy and exosomes are discussed as emerging, non-invasive methods with growing clinical applicability and improved sensitivity and specificity.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},349881,1790216570,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":41,"preview_page_count":19,"preview_urls":149},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Wang et al. World Journal of Surgical Oncology (2026) 24:86  \n[https://doi.org/10.1186/s12957-026-04215-8](https://doi.org/10.1186/s12957-026-04215-8)  \nWorld Journal of Surgical Oncology  \nREVIEW Open Access  \nResearch progress on early diagnostic markers for pancreatic cancer  \nLuwei Wang1, Zhixing Chen2, Xiao He2, Xiaoyu Kong3 and Yuanpeng Xiong2*  \nAbstract  \nPancreatic cancer (PC) is a highly aggressive malignancy characterized by insidious onset, rapid progression, and poor prognosis, predominantly affecting middle-aged and elderly men. Biomarker detection represents the most widely utilized approach for early PC diagnosis, encompassing both traditional and novel categories. Although traditional biomarkers like CA 19 − 9 are widely employed clinically, they carry a risk of false negatives in Lewis antigen-negative individuals, underscoring the urgent need for multi-parameter detection strategies to enhance accuracy. Integrating core indicators such as CEA and CA 242 can significantly improve the diagnostic effect of early PC and optimize diagnosis and treatment decisions. In recent years, breakthroughs have been made in biomarkers. Novel detection methods such as liquid biopsy and exosomes are entering the scope of clinical application. Due to their non-invasive nature, good sensitivity and specificity, these innovative biomarkers are gradually replacing traditional biomarkers and have become a new research focus. At present, single traditional biomarkers have limitations in diagnosing PC, while novel biomarkers lack extensive clinical verification. Meanwhile, there is no systematic review article specifically for early screening of PC to comprehensively evaluate the value and application prospects of these biomarkers. Therefore, this article provides a narrative review and comprehensive overview of the research progress on biomarkers related to the early diagnosis of PC in recent years.  \nKeywords Pancreatic cancer(PC), Biomarkers, Early diagnosis, CA 19 − 9, Liquid biopsy, Multi-parameter combined detection  \n*Correspondence: Yuanpeng Xiong [xypfy123@163.com](xypfy123@163.com)  \n1The First Clinical Medical College, Gannan Medical University, Ganzhou 341000, China  \n2Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China 3Department of Clinical Laboratory, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China  \nIntroduction  \nPancreatic cancer (PC) is a major digestive system malignancy, accounting for approximately 7% of all cancer-related deaths and representing one of the most aggressive gastrointestinal cancers. The overall 5-year survival rate for PC remains as low as 9%, and PC-related mortality is projected to double by 2060. When stratified by country, PC is the 3rd and 6th leading cause of cancerrelated death in the United States and China, respectively, representing a major contributor to cancer mortality in both nations [1, 2]. PC can be roughly classified into pancreatic head cancer and pancreatic body-tail cancer based on its anatomical location. When categorized by histological type, over 90% of PC are pancreatic ductal  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence an","cbCaisjdHi6U2Qv4","https://ap.wps.com/l/cbCaisjdHi6U2Qv4","pdf",973201,12,"English","# Abstract\n# Introduction\n## Classification and epidemiology of pancreatic cancer\n## Risk factors: modifiable and non-modifiable\n## Current limitations of traditional biomarkers\n# Review scope and aims\n## Multi-parameter detection and emerging biomarker technologies\n## Liquid biopsy and exosomes","[{\"question\":\"Why are early diagnostic biomarkers important for pancreatic cancer?\",\"answer\":\"Pancreatic cancer has an aggressive course and poor prognosis, so identifying it early is critical. Biomarker detection is the most widely used approach for early diagnosis.\"},{\"question\":\"What limitations exist for traditional biomarkers like CA 19−9?\",\"answer\":\"Traditional biomarkers can have false negatives in Lewis antigen-negative individuals and may show insufficient sensitivity and specificity.\"},{\"question\":\"How do multi-parameter detection strategies improve early diagnosis?\",\"answer\":\"Combining core indicators such as CEA and CA 242 can strengthen diagnostic performance and support better decisions regarding diagnosis and treatment.\"},{\"question\":\"What novel biomarker approaches are highlighted in recent research?\",\"answer\":\"Liquid biopsy and exosomes are discussed as emerging, non-invasive methods with growing clinical applicability and improved sensitivity and specificity.\"}]","Research progress on early diagnostic markers for pancreatic cancer | PDF",1790086069,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f1f18a21035770a15f6021dabe1692a.webp",983,1310,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce0e0c6a3d082c17e421f0c6451dd64b.webp",982,1309,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ecf9ba66c68c2f6337c9a4c1c3d5f4f.webp",981,1308,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a45010b0efa147b7c1cae211dc183c67.webp",980,1306]